Cardiff Oncology reported a net margin of -8,882.69% for the quarter ended Jun 2026. These financial ratios cover 61 quarters of results from Mar 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2011 | Jun2011 | Sep2011 | Dec2011 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin (Quarter)Gross Margin (Qtr) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin (Quarter)EBT Margin (Qtr) | -21,071.94% | -16,884.62% | -7,330.08% | -19,936.49% | -15,320.88% | -10,522.58% | -7,478.91% | -14,972.29% | -12,890.74% | -7,211.35% | -31,086.54% | -13,554.71% | -7,920.17% | -8,729.02% | -15,532.44% | -16,646.95% | -15,458.62% | -10,014.78% | -26,533.74% | -8,939.42% | |||||||||||||||||||||||||||||||||||||||||
| EBIT Margin (Quarter)EBIT Margin (Qtr) | -10,130.88% | -8,137.21% | -7,162.41% | -14,964.86% | -11,475.82% | -9,669.89% | -7,337.50% | -14,520.48% | -11,303.70% | -7,673.76% | -6,623.08% | -5,333.17% | -7,696.32% | -7,636.97% | -8,325.83% | -13,194.50% | -12,212.40% | -9,978.33% | -3,220.99% | -9,245.19% | |||||||||||||||||||||||||||||||||||||||||
| EBITDA Margin (Quarter)EBITDA Margin (Qtr) | -10,130.88% | -8,137.21% | -7,162.41% | -14,964.86% | -11,475.82% | -9,669.89% | -7,337.50% | -14,520.48% | -11,303.70% | -7,673.76% | -6,623.08% | -5,333.17% | -7,696.32% | -7,636.97% | -8,325.83% | -13,194.50% | -12,212.40% | -9,978.33% | -3,220.99% | -9,245.19% | |||||||||||||||||||||||||||||||||||||||||
| Operating Margin (Quarter)Operating Margin (Qtr) | -10,130.88% | -8,137.21% | -7,162.41% | -14,964.86% | -11,475.82% | -9,669.89% | -7,337.50% | -14,520.48% | -11,303.70% | -7,673.76% | -6,623.08% | -5,333.17% | -7,696.32% | -7,636.97% | -8,325.83% | -13,194.50% | -12,212.40% | -9,978.33% | -3,220.99% | -9,245.19% | |||||||||||||||||||||||||||||||||||||||||
| Net Margin (Quarter)Net Margin (Qtr) | -9,945.59% | -8,045.35% | -7,103.76% | -14,863.51% | -11,482.42% | -9,222.58% | -6,799.22% | -13,528.92% | -10,329.63% | -6,905.67% | -5,989.10% | -4,886.34% | -7,229.45% | -7,188.48% | -7,809.93% | -12,330.28% | -11,528.10% | -9,386.67% | -2,972.43% | -8,882.69% | |||||||||||||||||||||||||||||||||||||||||
| FCF Margin (Quarter)FCF Margin (Qtr) | -6,325.00% | -6,354.65% | -5,560.90% | -14,081.08% | -7,700.00% | -8,531.18% | -6,789.84% | -10,592.77% | -6,720.37% | -5,866.67% | -4,581.41% | -3,814.63% | -5,662.58% | -6,336.97% | -6,799.34% | -12,565.14% | -6,158.68% | -9,043.33% | -2,455.56% | ||||||||||||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets Average (Quarter)Assets Avg. (Qtr) | 136.65M | 142.52M | 145.43M | 144.37M | 135.23M | 127.45M | 119.91M | 111.37M | 102.00M | 92.95M | 85.04M | 77.84M | 70.04M | 64.47M | 80.04M | 91.00M | 80.27M | 69.76M | 62.83M | 49.61M | |||||||||||||||||||||||||||||||||||||||||
| Invested Capital (Quarter)Invested Cap. (Qtr) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset Utilization Ratio (Quarter)Asset Util. (Qtr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||||||||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage Ratio (Quarter)Interest Cover (Qtr) | -0.93 | -0.93 | -42.72 | -3.01 | -2.98 | -11.34 | -51.89 | -32.14 | -4.41 | -26.01 | -0.26 | -0.61 | -10.72 | -4.96 | -1.08 | -3.06 | -3.10 | -15.76 | -0.14 | -150.23 | |||||||||||||||||||||||||||||||||||||||||
| Debt Ratio (Quarter)Debt Ratio (Qtr) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Times Interest Earned (Quarter)Times Interest Earned (Qtr) | -0.93 | -0.93 | -42.72 | -3.01 | -2.98 | -11.34 | -51.89 | -32.14 | -4.41 | -26.01 | -0.26 | -0.61 | -10.72 | -4.96 | -1.08 | -3.06 | -3.10 | -15.76 | -0.14 | -150.23 | |||||||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Enterprise Value (Quarter)Enterprise Value (Qtr) | -140.05M | -134.05M | -140.82M | -129.36M | -122.01M | -114.30M | -105.27M | -96.97M | -89.43M | -81.36M | -74.82M | -67.19M | -60.32M | -57.67M | -91.75M | -79.89M | -70.96M | -60.59M | -58.30M | -59.82M | |||||||||||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales (Quarter)ROS (Qtr) | -2.11% | -1.69% | -0.73% | -1.99% | -1.53% | -1.05% | -0.75% | -1.50% | -1.29% | -0.72% | -3.11% | -1.36% | -0.79% | -0.87% | -1.55% | -1.66% | -1.55% | -1.00% | -2.65% | -0.89% | |||||||||||||||||||||||||||||||||||||||||
| Return on Capital Employed (Quarter)ROCE (Qtr) | -17.56% | -18.79% | -20.78% | -25.04% | -30.01% | -33.59% | -35.59% | -39.60% | -45.91% | -52.98% | -60.87% | -67.12% | -77.59% | -89.34% | -73.03% | -67.05% | -85.42% | -97.55% | -105.43% | -113.87% | |||||||||||||||||||||||||||||||||||||||||
| Return on Assets (Quarter)ROA (Qtr) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.01% | -0.01% | -0.01% | -0.02% | -0.01% | -0.01% | -0.01% | -0.01% | -0.02% | -0.01% |